• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CLEC11A在椎间盘退变中的驱动分子机制:一项全面的多组学研究

CLEC11A-Driven Molecular Mechanisms in Intervertebral Disc Degeneration: A Comprehensive Multi-Omics Study.

作者信息

Jiang Nizhou, Wang Quanxiang, Hu Zhenxin, Tian Xiliang

机构信息

Department of Spine Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, People's Republic of China.

Department of Otolaryngology-Head and Neck Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, People's Republic of China.

出版信息

J Inflamm Res. 2025 Jan 29;18:1353-1375. doi: 10.2147/JIR.S505296. eCollection 2025.

DOI:10.2147/JIR.S505296
PMID:39897524
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11787784/
Abstract

BACKGROUND

Intervertebral disc degeneration (IVDD) is a common chronic degenerative disease with a complex etiology involving genetic and environmental factors. However, the genetic pathogenesis and key driving factors of IVDD remain largely unknown.

METHODS

In this study, we combined MR with transcriptomic sequencing to identify key pathogenic genes implicated in IVDD. Further exploration using single-cell transcriptomics elucidated the specific cell types and pathways through which these genes modulate IVDD. Mediational MR analysis provided insights into the intermediary roles of 91 inflammatory factors and serum metabolites in the genetic causation pathway of IVDD. Finally, we validated these findings through in vitro experiments, confirming the regulatory roles of these critical genes in the progression of IVDD.

RESULTS

Transcriptomic and MR analyses identified six candidate pathogenic genes (AEN, CLEC11A, HMGN1, LRRC25, TAF7, and TREM1) significantly associated with IVDD. Subsequent single-cell analysis suggested that CLEC11A, TREM1, and HMGN1 may play pivotal roles in IVDD progression by modulating chondrocyte function and inflammatory responses. Mediation MR analysis further indicated that CLEC11A might significantly elevate IVDD risk by upregulating the inflammatory mediator ARTN and the uncharacterized serum metabolites X-12731 and X-18901 (ARTN: OR=1.078, 95% CI: 1.004-1.158, P=0.038; X-12731: OR=0.906, 95% CI: 0.852-0.960, P=0.043; X-18901: OR=1.090, 95% CI: 1.007-1.179, P=0.034). In vitro experiments demonstrated that overexpression of CLEC11A in nucleus pulposus cells significantly enhanced mRNA and protein expression of IVDD-related inflammatory markers; conversely, silencing CLEC11A markedly reduced these expressions. Similarly, overexpression of ARTN significantly increased, while knockdown decreased, the expression of these inflammatory markers in nucleus pulposus cells.

CONCLUSION

Our integrative multi-omics analysis indicates that CLEC11A exacerbates IVDD by upregulating ARTN and inducing metabolic dysregulation, thereby amplifying the inflammatory pathways that drive disease progression.

摘要

背景

椎间盘退变(IVDD)是一种常见的慢性退行性疾病,其病因复杂,涉及遗传和环境因素。然而,IVDD的遗传发病机制和关键驱动因素仍 largely未知。

方法

在本研究中,我们将磁共振成像(MR)与转录组测序相结合,以鉴定与IVDD相关的关键致病基因。使用单细胞转录组学进行的进一步探索阐明了这些基因调节IVDD的特定细胞类型和途径。中介MR分析深入了解了91种炎症因子和血清代谢物在IVDD遗传因果途径中的中介作用。最后,我们通过体外实验验证了这些发现,证实了这些关键基因在IVDD进展中的调节作用。

结果

转录组学和MR分析确定了六个与IVDD显著相关的候选致病基因(AEN、CLEC11A、HMGN1、LRRC25、TAF7和TREM1)。随后的单细胞分析表明,CLEC11A、TREM1和HMGN1可能通过调节软骨细胞功能和炎症反应在IVDD进展中起关键作用。中介MR分析进一步表明,CLEC11A可能通过上调炎症介质ARTN以及未鉴定的血清代谢物X-12731和X-18901来显著增加IVDD风险(ARTN:OR=1.078,95%CI:1.004-1.158,P=0.038;X-12731:OR=0.906,95%CI:0.852-0.960,P=0.043;X-18901:OR=1.090,95%CI:1.007-1.179,P=0.034)。体外实验表明髓核细胞中CLEC11A的过表达显著增强了IVDD相关炎症标志物的mRNA和蛋白质表达;相反,沉默CLEC11A显著降低了这些表达。同样,ARTN的过表达显著增加,而敲低则降低了髓核细胞中这些炎症标志物的表达。

结论

我们的综合多组学分析表明,CLEC11A通过上调ARTN和诱导代谢失调来加重IVDD,从而放大驱动疾病进展的炎症途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054f/11787784/bedce85d42f1/JIR-18-1353-g0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054f/11787784/126a1edcff94/JIR-18-1353-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054f/11787784/d183ba921d4b/JIR-18-1353-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054f/11787784/13f902816c91/JIR-18-1353-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054f/11787784/9bd7140a4e24/JIR-18-1353-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054f/11787784/5811b66949d0/JIR-18-1353-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054f/11787784/6c0d2e8f3680/JIR-18-1353-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054f/11787784/5b3023c98dc0/JIR-18-1353-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054f/11787784/e8ca70563798/JIR-18-1353-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054f/11787784/1d15aca0aff1/JIR-18-1353-g0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054f/11787784/66a84d677199/JIR-18-1353-g0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054f/11787784/37f3061a9adb/JIR-18-1353-g0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054f/11787784/bedce85d42f1/JIR-18-1353-g0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054f/11787784/126a1edcff94/JIR-18-1353-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054f/11787784/d183ba921d4b/JIR-18-1353-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054f/11787784/13f902816c91/JIR-18-1353-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054f/11787784/9bd7140a4e24/JIR-18-1353-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054f/11787784/5811b66949d0/JIR-18-1353-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054f/11787784/6c0d2e8f3680/JIR-18-1353-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054f/11787784/5b3023c98dc0/JIR-18-1353-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054f/11787784/e8ca70563798/JIR-18-1353-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054f/11787784/1d15aca0aff1/JIR-18-1353-g0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054f/11787784/66a84d677199/JIR-18-1353-g0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054f/11787784/37f3061a9adb/JIR-18-1353-g0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054f/11787784/bedce85d42f1/JIR-18-1353-g0012.jpg

相似文献

1
CLEC11A-Driven Molecular Mechanisms in Intervertebral Disc Degeneration: A Comprehensive Multi-Omics Study.CLEC11A在椎间盘退变中的驱动分子机制:一项全面的多组学研究
J Inflamm Res. 2025 Jan 29;18:1353-1375. doi: 10.2147/JIR.S505296. eCollection 2025.
2
LGR6 modulates intervertebral disc degeneration through regulation of macrophage efferocytosis.LGR6通过调节巨噬细胞的胞葬作用来调控椎间盘退变。
J Transl Med. 2025 Apr 25;23(1):475. doi: 10.1186/s12967-025-06427-0.
3
Nucleotide polymorphism-based study utilizes human plasma liposomes to discover potential therapeutic targets for intervertebral disc disease.基于核苷酸多态性的研究利用人血浆脂质体来发现椎间盘疾病的潜在治疗靶点。
Front Endocrinol (Lausanne). 2024 Aug 15;15:1403523. doi: 10.3389/fendo.2024.1403523. eCollection 2024.
4
Causal relationship between the blood immune cells and intervertebral disc degeneration: univariable, bidirectional and multivariable Mendelian randomization.血液免疫细胞与椎间盘退变的因果关系:单变量、双向和多变量孟德尔随机化。
Front Immunol. 2024 Jan 10;14:1321295. doi: 10.3389/fimmu.2023.1321295. eCollection 2023.
5
Glucose deprivation-induced disulfidptosis in human nucleus pulposus cells: a novel pathological mechanism of intervertebral disc degeneration.葡萄糖剥夺诱导人椎间盘细胞发生二硫键凋亡:椎间盘退变的一种新的病理机制。
Biol Direct. 2024 Sep 12;19(1):81. doi: 10.1186/s13062-024-00528-4.
6
Discovering Potential Mechanisms of Intervertebral Disc Disease Using Systematic Mendelian Randomization of Human Circulating Immunocytomics.利用人类循环免疫细胞组学的系统孟德尔随机化发现椎间盘疾病的潜在机制。
World Neurosurg. 2024 Sep;189:e688-e695. doi: 10.1016/j.wneu.2024.06.150. Epub 2024 Jul 4.
7
Integrated bulk and single-cell RNA sequencing to identify potential biomarkers in intervertebral disc degeneration.整合批量和单细胞RNA测序以鉴定椎间盘退变中的潜在生物标志物。
Eur J Med Res. 2025 Feb 14;30(1):102. doi: 10.1186/s40001-025-02346-4.
8
Role of arachidonic acid metabolism in intervertebral disc degeneration: identification of potential biomarkers and therapeutic targets via multi-omics analysis and artificial intelligence strategies.花生四烯酸代谢在椎间盘退变中的作用:通过多组学分析和人工智能策略鉴定潜在的生物标志物和治疗靶点。
Lipids Health Dis. 2023 Nov 25;22(1):204. doi: 10.1186/s12944-023-01962-5.
9
Tracing the pathways: how inflammatory cytokines and blood metabolites drive intervertebral disc degeneration.探寻路径:炎性细胞因子和血液代谢产物如何驱动椎间盘退变
Eur Spine J. 2025 Apr 26. doi: 10.1007/s00586-025-08850-9.
10
The role of micronutrients and serum metabolites in intervertebral disk degeneration: insights from a Mendelian randomization study and mediation analysis.微量营养素和血清代谢物在椎间盘退变中的作用:孟德尔随机化研究与中介分析的见解
Front Nutr. 2024 Oct 21;11:1428403. doi: 10.3389/fnut.2024.1428403. eCollection 2024.

本文引用的文献

1
An anti-senescence hydrogel with pH-responsive drug release for mitigating intervertebral disc degeneration and low back pain.一种具有pH响应性药物释放功能的抗衰老水凝胶,用于减轻椎间盘退变和腰痛。
Bioact Mater. 2024 Jul 26;41:355-370. doi: 10.1016/j.bioactmat.2024.07.031. eCollection 2024 Nov.
2
HMGN1 down-regulation in the diabetic kidney attenuates tubular cells injury and protects against renal inflammation via suppressing MCP-1 and KIM-1 expression through TLR4.在糖尿病肾病中下调 HMGN1 通过抑制 TLR4 减少单核细胞趋化蛋白-1 和肾损伤分子-1 的表达,从而减轻肾小管细胞损伤并发挥抗炎作用。
J Endocrinol Invest. 2024 Apr;47(4):1015-1027. doi: 10.1007/s40618-023-02292-0. Epub 2024 Feb 27.
3
Lactic acid promotes nucleus pulposus cell senescence and corresponding intervertebral disc degeneration via interacting with Akt.
乳酸通过与 Akt 相互作用促进髓核细胞衰老和相应的椎间盘退变。
Cell Mol Life Sci. 2024 Jan 12;81(1):24. doi: 10.1007/s00018-023-05094-y.
4
Serglycin secreted by late-stage nucleus pulposus cells is a biomarker of intervertebral disc degeneration.晚期髓核细胞分泌的糖蛋白聚糖是椎间盘退变的生物标志物。
Nat Commun. 2024 Jan 2;15(1):47. doi: 10.1038/s41467-023-44313-9.
5
Emerging role and therapeutic implications of p53 in intervertebral disc degeneration.p53在椎间盘退变中的新作用及治疗意义
Cell Death Discov. 2023 Dec 1;9(1):433. doi: 10.1038/s41420-023-01730-5.
6
Expression of Glial-Cell-Line-Derived Neurotrophic Factor Family Ligands in Human Intervertebral Discs.胶质细胞源性神经营养因子家族配体在人椎间盘的表达。
Int J Mol Sci. 2023 Nov 1;24(21):15874. doi: 10.3390/ijms242115874.
7
Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets.循环炎症蛋白的遗传学鉴定出了免疫介导疾病风险的驱动因素和治疗靶点。
Nat Immunol. 2023 Sep;24(9):1540-1551. doi: 10.1038/s41590-023-01588-w. Epub 2023 Aug 10.
8
Single-cell sequencing: New insights for intervertebral disc degeneration.单细胞测序:椎间盘退变的新见解。
Biomed Pharmacother. 2023 Sep;165:115224. doi: 10.1016/j.biopha.2023.115224. Epub 2023 Jul 27.
9
Single-cell transcriptomics reveals heterogeneity and intercellular crosstalk in human intervertebral disc degeneration.单细胞转录组学揭示了人类椎间盘退变中的异质性和细胞间串扰。
iScience. 2023 Apr 19;26(5):106692. doi: 10.1016/j.isci.2023.106692. eCollection 2023 May 19.
10
Physalin A alleviates intervertebral disc degeneration via anti-inflammatory and anti-fibrotic effects.酸浆素A通过抗炎和抗纤维化作用减轻椎间盘退变。
J Orthop Translat. 2023 Jan 25;39:74-87. doi: 10.1016/j.jot.2023.01.001. eCollection 2023 Mar.